BackSELLAS Life Sciences Group Overview
SELLAS Life Sciences Group Inc

SELLAS Life Sciences Group PEG Ratio

SELLAS Life Sciences Group (SLS) has a PEG ratio of -117.89, below the Healthcare sector average of 1.26.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-117.89

PEG Ratio

-117.89

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

Average PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

SELLAS Life Sciences Group (SLS) FAQ

As of the most recent data, SLS shows a PEG ratio of -117.89. That is below the Healthcare sector average of 1.26. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 1.26. SELLAS Life Sciences Group is at -117.89, which is lower that average. That is roughly 9476.6% below the sector mean. Use the comparison chart on this page to see how SLS stacks up against individual peers as well.

Investors watch SLS's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. SELLAS Life Sciences Group's latest reading is -117.89. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has SELLAS Life Sciences Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently -117.89) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 1.26, while SLS is at -117.89. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.